The biomarker test is a spinal tap test (also called a lumbar puncture) that uses a needle to remove cerebrospinal fluid (i.e ...

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise Researchers at Washington University School of Medicine in St. Louis have ...

Alzheimer’s is a devastating brain disease that affects nearly seven million Americans. But sometimes, it’s misdiagnosed.

Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for Alzheimer's Disease this ...

Doug Whitney was supposed to develop Alzheimer's by 50. Now scientists are trying to understand why his brain remains healthy ...

It is based on initial research led by Dr Maura Malpetti, who received the Race Against Dementia Fellowship in 2021 from the ...

By Heather Leigh Click here for updates on this story CLEARWATER, Florida (WFTS) — If you live with or take care of someone with dementia or Alzheimer’s disease, you know interactions with strangers ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

When dementia is diagnosed early on, there are more treatment and management options.Dr. Sudha Seshadri — the founding director of the Alzheimer’s and neurodegenerative diseases institute at UT Health ...

BURLINGTON, Mass. - Neuphoria Therapeutics Inc. (NASDAQ:NEUP), a biotechnology firm focused on neuropsychiatric treatments with a market capitalization of $7.27 million, is set to receive a $15 ...

When people think about cognitive decline, they often imagine the obvious symptoms: forgetfulness, confusion, or difficulty ...